{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,5]],"date-time":"2026-07-05T10:24:13Z","timestamp":1783247053495,"version":"3.54.6"},"reference-count":25,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,2,2]],"date-time":"2024-02-02T00:00:00Z","timestamp":1706832000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001840","name":"The Icelandic Centre for Research","doi-asserted-by":"publisher","award":["217707\u2013051"],"award-info":[{"award-number":["217707\u2013051"]}],"id":[{"id":"10.13039\/501100001840","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000015","name":"U.S. Department of Energy","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000015","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Chromatography B"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.jchromb.2024.124041","type":"journal-article","created":{"date-parts":[[2024,2,5]],"date-time":"2024-02-05T06:05:43Z","timestamp":1707113143000},"page":"124041","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Optimization and validation of a UPLC-MS\/MS assay for simultaneous quantification of 2,8-dihydroxyadenine, adenine, allopurinol, oxypurinol and febuxostat in human plasma"],"prefix":"10.1016","volume":"1235","author":[{"given":"Unnur A.","family":"Thorsteinsdottir","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hrafnhildur L.","family":"Runolfsdottir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Finnur F.","family":"Eiriksson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inger M. Sch.","family":"Agustsdottir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vidar O.","family":"Edvardsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Runolfur","family":"Palsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0649-8503","authenticated-orcid":false,"given":"Margret","family":"Thorsteinsdottir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jchromb.2024.124041_b0005","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1053\/ajkd.2001.26826","article-title":"Clinical features and genotype of adenine phosphoribosyltransferase deficiency in Iceland","volume":"38","author":"Edvardsson","year":"2001","journal-title":"Am. J. Kidney Dis."},{"key":"10.1016\/j.jchromb.2024.124041_b0010","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1681\/ASN.2009080808","article-title":"Phenotype and genotype characterization of adenine phosphoribosyltransferase deficiency","volume":"21","author":"Boll\u00e9e","year":"2010","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.jchromb.2024.124041_b0015","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1053\/j.ajkd.2015.10.023","article-title":"Kidney disease in adenine phosphoribosyltransferase deficiency","volume":"67","author":"Runolfsdottir","year":"2016","journal-title":"Am. J. Kidney Dis."},{"key":"10.1016\/j.jchromb.2024.124041_b0020","unstructured":"V.O. Edvardsson, A. Sahota, R. Palsson (2012) Adenine phosphoribosyltransferase deficiency. 30 Aug 2012 [Updated 2019 Sep 26]. In: M.P. Adam, H.H. Ardinger, R.A. Pagon, S.E. Wallace, L.J.H. Bean, K. Stephens, A. Amemiya, editors. GeneReviews\u00ae [Internet]. Seattle (WA): University of Washington, Seattle; 1993\u20132019. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK100238\/."},{"key":"10.1016\/j.jchromb.2024.124041_b0025","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.jchromb.2016.09.018","article-title":"Quantitative UPLC\u2013MS\/MS assay of urinary 2,8-dihydroxyadenine for diagnosis and management of adenine phosphoribosyltransferase deficiency","author":"Thorsteinsdottir","year":"2016","journal-title":"J. Chromatogr. B. Analyt. Technol. Biomed. Life Sci. 1036\u20131037"},{"key":"10.1016\/j.jchromb.2024.124041_b0030","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.ejim.2017.10.007","article-title":"Comparison of the effect of allopurinol and febuxostat on urinary 2,8-dihydroxyadenine excretion in patients with adenine phosphoribosyltransferase deficiency (APRTd): A clinical trial","volume":"48","author":"Edvardsson","year":"2018","journal-title":"Eur. J. Intern. Med."},{"key":"10.1016\/j.jchromb.2024.124041_b0035","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.jpha.2016.05.005","article-title":"Simultaneous analysis of allopurinol and oxypurinol using a validated liquid chromatography \u2013 tandem mass spectrometry method in human plasma","volume":"7","author":"Rathod","year":"2017","journal-title":"J. Pharm. Anal."},{"key":"10.1016\/j.jchromb.2024.124041_b0040","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1080\/10826076.2011.534692","article-title":"Validated RP-LC-MS\/MS method for the simultaneous determination of allopurinol and its major metabolite, oxypurinol, in human plasma","volume":"34","author":"Kasawar","year":"2011","journal-title":"J. Liq. Chromatogr. Relat. Technol."},{"key":"10.1016\/j.jchromb.2024.124041_b0045","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.jchromb.2013.09.028","article-title":"Determination of allopurinol and oxypurinol in human plasma and urine by liquid chromatography-tandem mass spectrometry","volume":"941","author":"Liu","year":"2013","journal-title":"J. Chromatogr. B."},{"key":"10.1016\/j.jchromb.2024.124041_b0050","first-page":"2","article-title":"Rapid and sensitive LC-MS\/MS method for the analysis of allopurinol in human plasma","author":"Reddy","year":"2014","journal-title":"Int. J. Pharma. Bio. Sci."},{"key":"10.1016\/j.jchromb.2024.124041_b0055","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1186\/2193-1801-2-194","article-title":"Bioequivalance and pharmacokinetic study of febuxostat in human plasma by using LC-MS\/MS with liquid liquid extraction method","volume":"2","author":"Chandu","year":"2013","journal-title":"SpringerPlus."},{"key":"10.1016\/j.jchromb.2024.124041_b0060","doi-asserted-by":"crossref","unstructured":"S.P. Kovvasu, S. Yeung, P. Kunamaneni, B. Kodali, Bioanalysis of febuxostat in human plasma by liquid chromatography \/ tandem mass spectrometry, Int. J. Pharmtech. Res. 11 (2018) 168\u2013176. 10.20902\/IJPTR.2018.11207.","DOI":"10.20902\/IJPTR.2018.11207"},{"key":"10.1016\/j.jchromb.2024.124041_b0065","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1002\/dta.420","article-title":"Determination of febuxostat in human plasma using ultra-performance liquid chromatography tandem mass spectrometry","volume":"5","author":"Lukram","year":"2012","journal-title":"Drug. Test. Anal."},{"key":"10.1016\/j.jchromb.2024.124041_b0070","article-title":"Pharmacokinetics and bioequivalence of two formulations of febuxostat 40-Mg and 80-Mg tablets: A randomized, open-label, 4-way crossover study in healthy Chinese male volunteers","volume":"11","author":"Luo","year":"2016","journal-title":"PLoS One."},{"key":"10.1016\/j.jchromb.2024.124041_b0075","doi-asserted-by":"crossref","first-page":"37","DOI":"10.14302\/issn.2328-0182.japst-12-173","article-title":"Liquid chromatography tandem mass spectrometry method for determination of febuxostat in human plasma to support a bioequivalence study","volume":"1","author":"Patel","year":"2013","journal-title":"J. Adv. Pharm. Sci. Technol."},{"key":"10.1016\/j.jchromb.2024.124041_b0080","first-page":"396","article-title":"Development of a simple LC-MS\/MS method for the determination of febuxostat in human plasma and its application to a bioequivalence study","volume":"68","author":"Shi","year":"2013","journal-title":"Pharmazie."},{"key":"10.1016\/j.jchromb.2024.124041_b0085","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1002\/bmc.2936","article-title":"A sensitive LC-MS\/MS method for the quantification of febuxostat in human plasma and its pharmacokinetic application","volume":"27","author":"Vaka","year":"2013","journal-title":"Biomed. Chromatogr."},{"key":"10.1016\/j.jchromb.2024.124041_b0090","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1002\/bmc.2744","article-title":"Development and validation of a liquid chromatography-tandem mass spectrometry method for the determination of febuxostat in human plasma","volume":"27","author":"Wang","year":"2013","journal-title":"Biomed. Chromatogr."},{"key":"10.1016\/j.jchromb.2024.124041_b0095","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/0009-8981(89)90323-9","article-title":"Reversed-phase high-performance liquid-chromatography of 2,8-dihydroxyadenine in serum and urine with electrochemical detection","volume":"181","author":"Kojima","year":"1989","journal-title":"Clin. Chim. Acta."},{"key":"10.1016\/j.jchromb.2024.124041_b0100","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/00365518009091520","article-title":"Plasma concentration and renal excretion of adenine and 2,8-dihydroxyadenine after administration of adenine in man","volume":"40","author":"Ericson","year":"1980","journal-title":"Scand. J. Clin. Lab. Invest."},{"key":"10.1016\/j.jchromb.2024.124041_b0105","unstructured":"U.S. Food and Drug Administration (FDA), M10 Bioanalytical Method Validation and Study Sample Analysis Guidance for Industry, (https:\/\/www.fda.gov\/media\/162903\/download) (2022)."},{"key":"10.1016\/j.jchromb.2024.124041_b0110","unstructured":"U.S. Food and Drug Administration (FDA), Bioanalytical Method Validation Guidance for Industry, (https:\/\/www.fda.gov\/regulatory-information\/search-fdaguidance-documents\/bioanalytical-method-validation-guidance-industry) (2018)."},{"key":"10.1016\/j.jchromb.2024.124041_b0115","doi-asserted-by":"crossref","first-page":"3109","DOI":"10.1021\/ja01189a081","article-title":"A synthesis of isoguanine labeled with isotopic nitrogen","volume":"70","author":"Bendich","year":"1948","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.jchromb.2024.124041_b0120","doi-asserted-by":"crossref","first-page":"2587","DOI":"10.1021\/ja01162a067","article-title":"The Ultraviolet absorption spectra of pyrimidines and purines","volume":"72","author":"Cavalieri","year":"1950","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.jchromb.2024.124041_b0125","series-title":"Patient Centric Blood Sampling and Quantitative Analysis","first-page":"277","article-title":"Simplification of home urine sampling for measurement of 2,8-dihydroxyadenine in patients with adenine phosphoribosyltransferase deficiency","author":"Thorsteinsdottir","year":"2023"}],"container-title":["Journal of Chromatography B"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1570023224000497?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1570023224000497?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T23:12:59Z","timestamp":1761606779000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1570023224000497"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":25,"alternative-id":["S1570023224000497"],"URL":"https:\/\/doi.org\/10.1016\/j.jchromb.2024.124041","relation":{},"ISSN":["1570-0232"],"issn-type":[{"value":"1570-0232","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Optimization and validation of a UPLC-MS\/MS assay for simultaneous quantification of 2,8-dihydroxyadenine, adenine, allopurinol, oxypurinol and febuxostat in human plasma","name":"articletitle","label":"Article Title"},{"value":"Journal of Chromatography B","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jchromb.2024.124041","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"124041"}}